An inhibitor of p38 and JNK MAP kinases prevents activation of caspase and apoptosis of cultured cerebellar granule neurons

Japanese Journal of Pharmacology

Volumn 79, Issue 3, 1999, Pages 369-378

  Harada, Jun ^a   Sugimoto, Masahiko ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

Apoptosis; Caspase 3; Cerebellar granule cell; Jun N terminal kinase; p38

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASPASE; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; NERVE CELL CULTURE; NONHUMAN; RAT;

EID: 0032919249     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.79.369     Document Type: Article

References (52)

1. Cano E and Mahadevan LC: Parallel signal processing among mammalian MAPKs. Trends Biochem Sci 20, 117-122 (1995)
2. Robinson MJ and Cobb MH: Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9, 180-186 (1997)
3. Minden A and Karin M: Regulation and function of the JNK subgroup of MAP kinases. Biochim Biophys Acta 1333, F85-F104 (1997)
4. Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331 (1995)
5. Estus S, Zaks WJ, Freeman ES, Gruda M, Bravo R and Johnson EM Jr: Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J Cell Biol 127, 1717-1727 (1994)
6. Ham J, Babij C, Whitfield J, Pfarr CM, Lallemand D, Yaniv M and Rubin LL: A c-jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14, 927-939 (1995)
7. Yang DD, Kuan C-Y, Whitmarsh AJ, Rincon M, Zheng TS, Davis RJ, Rakic P and Flavell RA: Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389, 865-870 (1997)
8. Herdegen T, Skene P and Bahr M: The c-Jun transcription factor - bipotential mediator of neuronal death, survival and regeneration. Trends Neurosci 20, 227-231 (1997)
9. Watson A, Eilers A, Lallemand D, Kyriakis J, Rubin LL and Ham J: Phosphorylation of c-Jun is necessary for apoptosis induced by survival signal withdrawal in cerebellar granule neurons. J Neurosci 18, 751-762 (1998)
10. Heidenreich KA and Kummer JL: Inhibition of p38 mitogen-activated protein kinase by insulin in cultured fetal neurons. J Biol Chem 271, 9891-9894 (1996)
11. Kawasaki H, Morooka T, Shimohama S, Kimura J, Hirano T, Gotoh Y and Nishida E: Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J Biol Chem 272, 18518-18521 (1997)
12. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, Strickler JE, Mclaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL and Young PR: A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739-746 (1994)
13. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR and Lee JC: SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364, 229-233 (1995)
14. Gorman AM, Orrenius S and Ceccatelli S: Apoptosis in neuronal cells: role of caspases. Neuroreport 9, R49-R55 (1998)
15. Pettmann B and Henderson CE: Neuronal cell death. Neuron 20, 633-647 (1998)
16. Harada J and Sugimoto M: Polyamines prevent apoptotic cell death in cultured cerebellar granule neurons. Brain Res 753, 251-259 (1997)
17. Harada J and Sugimoto M: Inhibitors of interleukin-1β-converting enzyme-family proteases (caspases) prevent apoptosis without affecting decreased cellular ability to reduce 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide in cerebellar granule cells. Brain Res 793, 231-243 (1998)
18. Armstrong RC, Aja TJ, Hoang KD, Gaur S, Bai X, Alnemri ES, Litwack G, Karanewsky DS, Fritz LC and Tomaselli KJ: Activation of the CED3/ICE-related protease CPP32 in cerebellar granule neurons undergoing apoptosis but not necrosis. J Neurosci 17, 553-562 (1997)
19. Nath R, Raser KJ, McGinnis K, Nadimpalli R, Stafford D and Wang KKW: Effects of ICE-like proteases and calpain inhibitors on neuronal apoptosis. Neuroreport 8, 249-255 (1996)
20. Eldadah BA, Yakovlev AG and Faden AI: The role of CED-3-related proteases in apoptosis of cerebellar granule cells. J Neurosci 17, 6105-6113 (1997)
21. Park DS, Stefenis L, Yan CYI, Farinelli SE and Greene L: Ordering the cell death pathway: differential effects of BCL2, an interleukin-1-converting enzyme family protease inhibitor, and other survival agents on JNK activation in serum/nerve growth factor-deprived PC12 cells. J Biol Chem 271, 21898-21905 (1996)
22. Deshmukh M, Vasilakos J, Deckwerth TL, Lampe PA, Shivers BD, Johnson EM Jr: Genetic and metabolic status of NGF-deprived sympathetic neurons saved by an inhibitor of ICE family proteases. J Cell Biol 135, 1341-1354 (1996)
23. Liu Z-g, Hsu H, Goeddel DV and Karin M: Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87, 565-576 (1996)
24. Yeh W-C, Shahihian A, Speiser D, Kraunus J, Billia F, Wakeham A, Luis de la Pompa J, Ferrick D, Hum B, Iscove N, Ohashi P, Rothe M, Goeddel DV and Mak TW: Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7, 715-725 (1997)
25. Beyaert R, Cuenda A, Vanden W, Stephane P, Lee JC, Haegeman G, Cohen P and Fiers W: The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumour necrosis factor. EMBO J 15, 1914-1923 (1996)
26. Ichijo H, Nishida E, Irie K, Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K and Gotoh Y: Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275, 90-94 (1997)
27. Wilson DJ, Fortner KA, Lynch DH, Mattingly RR, Macara IG, Posada JA and Budd RC: JNK, but not MAPK, activation is associated with Fas-mediated apoptosis in human T cells. Eur J Immunol 26, 989-994 (1996)
28. Juo P, Kuo CJ, Reynolds SE, Konz RF, Raingeaud J, Davis RJ, Biemann H-P and Blenis J: Fas activation of the p38 mitogen-activated protein kinase signaling pathway requires ICE/CED-3 family proteases. Mol Cell Biol 17, 24-35 (1997)
29. Lenczowski JM, Dominguez L, Eder AM, King LB, Zacharchuk CM and Ashwell JD: Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis. Mol Cell Biol 17, 170-181 (1997)
30. Huang S, Jiang Y, Li Z, Nishida E, Mathias P, Lin S, Ulevitch RJ, Nemerow GR and Han J: Apoptosis signaling pathway in T cells is composed of ICE/CED-3 family proteases and MAP kinase kinase 6b. Immunity 6, 739-749 (1997)
31. Toyoshima F, Moriguchi T and Nishida E: Fas induces cytoplasmic apoptotic responses and activation of the MKK7-JNK/SAPK and MKK6-p38 pathways independent of CPP32-like proteases. J Cell Biol 139, 1005-1015 (1997)
32. Miller TM and Johnson EM Jr: Metabolic and genetic analyses of apoptosis in potassium-serum-deprived rat cerebellar granule cells. J Neurosci 16, 7487-7495 (1996)
33. Herdegen T, Claret F-X, Kallunki T, Martin-Villalba A, Winter C, Hunter T and Karin M: Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury. J Neurosci 18, 5124-5135 (1998)
34. Whitmarsh AJ, Yang S-H, Su MS-S, Sharrocks AD and Davis RJ: Role of p38 and JNK Mitogen-activated protein kinases in the activation of ternary complex factors. Mol Cell Biol 17, 2360-2371 (1997)
35. Clerk A and Sugden PH: The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs). FEBS Lett 426, 93-96 (1998)
36. Van Dam H, Wilhelm D, Herr I, Steffen A, Herrlich P and Angel P: ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic stress. EMBO J 14, 1798-1811 (1995)
37. Han J, Jiang Y, Kiavchenko VV and Ulevitch RJ: Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386, 296-299 (1997)
38. Hazzalin CA, Cuenda A, Cano E, Cohen P and Mahadevan LC: Effects of the inhibition of p38/RK MAP kinase on induction of five fos and jun genes by diverse stimuli. Oncogene 15, 2321-2331 (1997)
39. Jiang Y, Chen C, Li Z, Guo W, Gegner JA, Lin S and Han J: Characterization of the structure and function of a new mitogen-activated protein kinase (p38β). J Biol Chem 271, 17920-17926 (1996)
40. Kumar S, Mcdonnell PC, Gum RJ, Hand AT, Lee JC and Young PR: Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun 235, 533-538 (1997)
41. Li Z, Jiang Y, Ulevitch RJ and Han J: The primary structure of p38γ: a new member of p38 group of MAP kinases. Biochem Biophys Res Commun 228, 334-340 (1996)
42. Wang XS, Diener K, Manthey CL, Wang S-W, Rosenzweig B, Bray J, Delaney J, Cole CN, Chan-Hui P-Y, Mantlo N, Lichenstein HS, Zukowski M and Yao Z: Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. J Biol Chem 272, 23668-23674 (1997)
43. Jiang Y, Gram H, Zhao M, New L, Gu J, Feng L, Padova FD, Ulevitch RJ and Han J: Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p385. J Biol Chem 272, 30122-30128 (1997)
44. Stein B, Yang MX, Young DB, Janknecht R, Hunter T, Murray BW and Barbosa MS: p38-2, a novel mitogen-activated protein kinase with distinct properties. J Biol Chem 272, 19509-19517 (1997)
45. Xu X, Raber J, Yang D, Su B and Mucke L: Dynamic regulation of c-Jun N-terminal kinase activity in mouse brain by environmental stimuli. Proc Natl Acad Sci USA 94, 12655-12660 (1997)
46. Enslen H, Tokumitsu H, Stork PS, Davis RJ and Soderling TR: Regulation of mitogen-activated protein kinases by a calcium /calmodulin-dependent protein kinase cascade. Proc Natl Acad Sci USA 93, 10803-10808 (1996)
47. 2+/calmodulin-dependent protein kinase activity. Neuroscience 57, 9-20 (1993)
48. 2+-and stimulus duration-dependent switch for hippocampal gene expression. Cell 87, 1203-1214 (1996)
49. 2+-induced regulation of ion channel and MAP kinase functions. Nature 376, 737-745 (1995)
50. Tokiwa G, Dikic I, Lev S and Schlessinger: Activation of Pyk2 by stress signals and coupling with JNK signaling pathway. Science 273, 792-794 (1996)
51. Camps M, Nichols A, Gillieron C, Antonsson B, Muda M, Chabert C, Boschert U and Arkinstall S: Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science 280, 1262-1265 (1998)
52. Whitmarsh AJ, Cavanagh J, Tournier C, Yasuda J and Davis RJ: A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 281, 1671-1674 (1998)